The overexpression of CA-IX in the hypoxic tumor is associated with tumor aggression, poor prognosis, and radio- and chemotherapy resistance (Akocak & Ilies, 2014; Muz et al., 2015; Shabana et al., 2018). The gene discussed is CA9; the disease is neoplasm.